Novartis Wins Appeal To Patent Pancreas Cancer Drug
Pharmaceutical giant Novartis Pharma AG has successfully beaten back attempts by competitors to invalidate its patent for a cancer therapy, with a European appeal board concluding the therapy was inventive....To view the full article, register now.
Already a subscriber? Click here to view full article